IONIS PHARMACEUTICALS INC reports

Company location: Carlsbad, CA
Fiscal year end: 31 December

IONIS PHARMACEUTICALS INC has filed 2,668 SEC EDGAR filings since 12 Jun 1996

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 276-300 of 1,000 matching filings.

Per page

25

Current page

12

4

PRIMARY DOCUMENT

Filing date: 17 Jul 2025
Reporting date: 15 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Jul 2025
Reporting date: 15 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Jul 2025
Reporting date: 15 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Jul 2025
Reporting date: 15 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 15 Jul 2025
Reporting date: 11 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jul 2025
Reporting date: 01 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jul 2025
Reporting date: 01 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jul 2025
Reporting date: 01 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jul 2025
Reporting date: 01 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jul 2025
Reporting date: 01 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jul 2025
Reporting date: 01 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jul 2025
Reporting date: 01 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jul 2025
Reporting date: 01 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 Jul 2025
Reporting date: 01 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-19125

8-K

Filing date: 12 Jun 2025
Reporting date: 12 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-19125

8-K

Filing date: 10 Jun 2025
Reporting date: 05 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-19125

8-K

Filing date: 19 May 2025
Reporting date: 19 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 02 May 2025
Reporting date: 01 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-19125

IONIS PHARMACEUTICALS, INC. 10-Q 3-31-2025

Filing date: 30 Apr 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-19125

8-K

Filing date: 30 Apr 2025
Reporting date: 30 Apr 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

ARS File 000-19125

ARS

Filing date: 25 Apr 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 000-19125

DEFA14A

Filing date: 25 Apr 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 000-19125

DEF 14A

Filing date: 25 Apr 2025
Reporting date: 05 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Apr 2025
Reporting date: 15 Apr 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Apr 2025
Reporting date: 15 Apr 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .